Comparison between Standard medical therapy plus intravenous albumin vs standard medical therapy alone in patients with variceal upper gastrointestinal bleed.
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2022/10/046898
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients with cirrhosis and variceal bleed presenting within 24 hours of bleed
2.Age 18-65 years
3.Willing to participate in the study
1.Patients with Child A cirrhosis
2.Patients with normal serum albumin
3.Patients undergoing pre-emptive TIPS
4.Patients with acute on chronic liver failure (diagnosed based on the EASL-CLIF criteria15) at presentation
5.Pregnancy
6.Hypersensitivity to albumin
7.Patients with hepatocellular cancer
8.Patients on anti-platelets or anticoagulants
9.Patients with other co-morbidities such as coronary artery disease, chronic obstructive pulmonary disease, chronic kidney disease and neuromuscular disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.